Sustainability

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Clinical Research Policy

By conducting clinical research, Kyowa Hakko Kirin aspires to contribute to the enhancement of medical care, the advancement of medical and pharmaceutical sciences, and the health and well-being of people around the world.
When engaging in clinical research, we give maximum consideration to the protection of the human rights and safety of patients participating in the research. Furthermore, we strive to comply with relevant laws and regulations, and secure transparency in clinical research, scientific validity, independence and reliability.

We have established and are implementing the Clinical Research Policy, which summarizes our approach to clinical research and code of conduct.

Kyowa Hakko Kirin Clinical Research Policy (excerpts)

Kyowa Hakko Kirin proceeds with clinical research for the purpose of providing appropriate information of scientific and clinical significance, thereby contributing to the enhancement of medical care, the advancement of medical and pharmaceutical science, and, moreover, the health and well-being of people around the world.

Kyowa Hakko Kirin acts in accordance with the following principles when engaging in clinical research.

  1. Respect patients’ human rights
  2. Comply with laws and regulations
  3. Ensure transparency
  4. Secure scientific validity, independence and reliability
  5. Engage in clinical research on a contract basis

Established: August 28, 2014

*
This policy applies only to domestic clinical research.
*
See here for Kyowa Hakko Kirin’s clinical research.


To Page Top